These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 9513723
1. Type I growth factor receptors: current status and future work. Gullick WJ. Biochem Soc Symp; 1998; 63():193-8. PubMed ID: 9513723 [Abstract] [Full Text] [Related]
2. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y. Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426 [Abstract] [Full Text] [Related]
3. Bivalence of EGF-like ligands drives the ErbB signaling network. Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y. EMBO J; 1997 Aug 15; 16(16):4938-50. PubMed ID: 9305636 [Abstract] [Full Text] [Related]
4. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma. Vaidya P, Kawarada Y, Higashiguchi T, Yoshida T, Sakakura T, Yatani R. J Pathol; 1996 Feb 15; 178(2):140-5. PubMed ID: 8683379 [Abstract] [Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) signaling in cancer. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS. Gene; 2006 Jan 17; 366(1):2-16. PubMed ID: 16377102 [Abstract] [Full Text] [Related]
6. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action? Normanno N, Maiello MR, De Luca A. J Cell Physiol; 2003 Jan 17; 194(1):13-9. PubMed ID: 12447985 [Abstract] [Full Text] [Related]
10. Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior. Bacus SS, Zelnick CR, Plowman G, Yarden Y. Am J Clin Pathol; 1994 Oct 17; 102(4 Suppl 1):S13-24. PubMed ID: 7942609 [Abstract] [Full Text] [Related]
12. Signal transduction and oncogenesis by ErbB/HER receptors. Marmor MD, Skaria KB, Yarden Y. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):903-13. PubMed ID: 14967450 [Abstract] [Full Text] [Related]
13. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. Slesak B, Harlozinska A, Porebska I, Bojarowski T, Lapinska J, Rzeszutko M, Wojnar A. Anticancer Res; 1998 Mar 01; 18(4A):2727-32. PubMed ID: 9703936 [Abstract] [Full Text] [Related]
14. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Motoyama AB, Hynes NE, Lane HA. Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928 [Abstract] [Full Text] [Related]
15. The ErbB/HER receptor protein-tyrosine kinases and cancer. Roskoski R. Biochem Biophys Res Commun; 2004 Jun 18; 319(1):1-11. PubMed ID: 15158434 [Abstract] [Full Text] [Related]
16. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Piepkorn M, Predd H, Underwood R, Cook P. Arch Dermatol Res; 2003 Jul 18; 295(3):93-101. PubMed ID: 12768307 [Abstract] [Full Text] [Related]